News & Updates

Elastic tape alleviates dyspnoea, improves health status in COPD

Use of the elastic tape, while having no effect on daily life physical activity, appears to be beneficial to men with moderate to very severe chronic obstructive pulmonary disease (COPD) in terms of dyspnoea symptoms, health status, and quality of life, as shown in a study.

N-Acetylcysteine Chronic Obstructive Pulmonary Disease Treatable Traits Approach

Thalidomide reduces recurrent GI bleeding in patients with small-intestinal angiodysplasia

Among patients with recurrent gastrointestinal (GI) bleeding due to small-intestinal angiodysplasia (SIA), treatment with thalidomide resulted in fewer bleeding episodes compared with placebo, according to a recent study.

Original New Drug Application Approvals by US FDA (01-15 November 2023)

New drug applications approved by US FDA as of 01-15 November  2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Is salt in foods a risk factor for type 2 diabetes?

Frequently adding salt to foods increases not only the risk of hypertension but the risk of type 2 diabetes (T2D) as well, as reported in a large study.

Residual disease in axSpA more prevalent, severe in female patients

Patients with axial spondyloarthritis (axSpA) who are in a low disease activity (LDA) state or in remission tend to experience residual disease, which occurs more frequently among female patients, reveals a recent study.

Paclitaxel-coated devices do not increase mortality risk

An updated patient-level meta-analysis refutes claims that paclitaxel-coated devices for femoropopliteal interventional procedures heighten the risk of death. The recent study presented at TCT 2023 has found no association between exposure to paclitaxel and mortality.